...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?

Hi Bear,

I wonder if Zenith has pulled out of the virtual AACR conference completely,

it would shock me at all with no explanation 

Share
New Message
Please login to post a reply